Value Assessment Initiative
The PhRMA Foundation’s Value Assessment Initiative promotes the development of advanced value-assessment so decision makers have better tools to assess high- and low-value care in the U.S. health system. The initiative funds new research and innovative efforts to assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency.
Centers of Excellence
Sam Emaminejad, PhD, is an Assistant Professor in the Electrical and Computer Engineering department at UCLA and the founder and director of the Interconnected & Integrated Bioelectronics Lab. His lab focuses on the development of an ecosystem of integrated wearable, mobile, and in-vivo physiological and environmental monitoring platforms to enable personalized and precision medicine. Dr. Emaminejad, who received a PhRMA Research Starter Grant in Translational Medicine and Therapeutics in 2018, has received numerous honors and awards, including a Distinguished Young Investigator Award for leading a multi-center program on remote patient monitoring with UCLA, Intermountain Healthcare and Stanford School of Medicine. He recently discussed his work in a short online video.
Utilize our site for updates and announcements or follow PhRMA Foundation on twitter @PhRMAFoundation
PhRMA Foundation Surpasses $2.8 Million in Funding for Leaders in Value Assessment
The PhRMA Foundation has announced a new cycle of awards to support transformative strategies that better assess the value of medicines and health care services, improve patient outcomes and reduce inefficiency in health care. More than $2.8 million has been provided to date to establish four national value-assessment Centers of Excellence and support the work of several researchers focused on value-based health care. Learn more about the awards and how to apply for 2019 or 2020 funding.
2019 Value Assessment Challenge Award Recipients Announced
The PhRMA Foundation has announced the winners of the 2019 Value Assessment Challenge Awards. Designed to encourage innovative approaches in defining and measuring value in health care, this year’s awards focused on novel proposals to improve value assessment methods that move beyond the quality-adjusted life year (QALY).
Congratulations to our 2019 Awards Recipients!
Over the last year, the PhRMA Foundation provided millions in funding to the nation’s leading young researchers, while supporting important new other research in areas such as Value Assessment in health care. See a complete list of the award recipients here.